| 000 | 01640 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514180622.0 | ||
| 264 | 0 | _c20040323 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a0022-3050 | ||
| 024 | 7 |
_a10.1136/jnnp.2003.014993 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMosconi, L | |
| 245 | 0 | 0 |
_aBrain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease. _h[electronic resource] |
| 260 |
_bJournal of neurology, neurosurgery, and psychiatry _cMar 2004 |
||
| 300 |
_a370-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlzheimer Disease _xdiagnostic imaging |
| 650 | 0 | 4 | _aApolipoprotein E4 |
| 650 | 0 | 4 |
_aApolipoproteins E _xgenetics |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorodeoxyglucose F18 |
| 650 | 0 | 4 | _aGene Dosage |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTomography, Emission-Computed |
| 700 | 1 | _aNacmias, B | |
| 700 | 1 | _aSorbi, S | |
| 700 | 1 | _aDe Cristofaro, M T R | |
| 700 | 1 | _aFayazz, M | |
| 700 | 1 | _aTedde, A | |
| 700 | 1 | _aBracco, L | |
| 700 | 1 | _aHerholz, K | |
| 700 | 1 | _aPupi, A | |
| 773 | 0 |
_tJournal of neurology, neurosurgery, and psychiatry _gvol. 75 _gno. 3 _gp. 370-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/jnnp.2003.014993 _zAvailable from publisher's website |
| 999 |
_c14688664 _d14688664 |
||